These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1409 related items for PubMed ID: 31423723

  • 1. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [Abstract] [Full Text] [Related]

  • 2. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
    Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937
    [Abstract] [Full Text] [Related]

  • 3. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Atherosclerosis; 2020 May; 301():54-64. PubMed ID: 32330691
    [Abstract] [Full Text] [Related]

  • 4. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Philip F, Stewart S, Southard JA.
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):38-48. PubMed ID: 26916633
    [Abstract] [Full Text] [Related]

  • 5. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M, Räber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, Ostojic M, Iñiguez A, Tüller D, Serra A, Baumbach A, von Birgelen C, Hernandez-Antolin R, Roffi M, Mainar V, Valgimigli M, Serruys PW, Jüni P, Windecker S.
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [Abstract] [Full Text] [Related]

  • 6. Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?
    Costa F, Brugaletta S, Pernigotti A, Flores-Ulmanzor E, Ortega-Paz L, Cequier A, Iniguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, van Es GA, Backx B, Valgimigli M, Serruys P, Sabaté M.
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e007705. PubMed ID: 31451013
    [Abstract] [Full Text] [Related]

  • 7. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, Shin DH, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [Abstract] [Full Text] [Related]

  • 9. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S, Effat M, Rahman S, Abdallah M, Leesar M.
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [Abstract] [Full Text] [Related]

  • 10. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Jüni P, Windecker S.
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [Abstract] [Full Text] [Related]

  • 11. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K.
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [Abstract] [Full Text] [Related]

  • 12. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K, Lyu S, Liu H, Song X, Yuan F, Xu F, Zhang M, Wang W, Zhang M, Zhang D, Tian J.
    Cardiovasc Diabetol; 2019 Sep 17; 18(1):119. PubMed ID: 31530274
    [Abstract] [Full Text] [Related]

  • 13. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A.
    JACC Cardiovasc Interv; 2013 Dec 17; 6(12):1267-74. PubMed ID: 24355117
    [Abstract] [Full Text] [Related]

  • 14. Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Fukutomi M, Toriumi S, Ogoyama Y, Oba Y, Takahashi M, Funayama H, Kario K.
    Catheter Cardiovasc Interv; 2019 Apr 01; 93(5):E262-E268. PubMed ID: 30244539
    [Abstract] [Full Text] [Related]

  • 15. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G, PRODIGY Investigators.
    JACC Cardiovasc Interv; 2014 Jan 01; 7(1):20-8. PubMed ID: 24332420
    [Abstract] [Full Text] [Related]

  • 16. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D, Crake T, Lee V.
    Crit Pathw Cardiol; 2018 Jun 01; 17(2):77-82. PubMed ID: 29768315
    [Abstract] [Full Text] [Related]

  • 17. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
    Ha FJ, Nogic J, Montone RA, Cameron JD, Nerlekar N, Brown AJ.
    Cardiovasc Revasc Med; 2018 Jun 01; 19(7 Pt B):837-844. PubMed ID: 29685385
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease.
    Cui K, Lyu S, Song X, Liu H, Yuan F, Xu F, Zhang M, Wang W, Zhang M, Zhang D, Dai J, Tian J.
    Coron Artery Dis; 2019 May 01; 30(3):188-195. PubMed ID: 30724818
    [Abstract] [Full Text] [Related]

  • 19. Prediabetes versus type 2 diabetes mellitus based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction after successful newer-generation drug-eluting stent implantation.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Diab Vasc Dis Res; 2021 May 01; 18(1):1479164121991505. PubMed ID: 33535819
    [Abstract] [Full Text] [Related]

  • 20. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V, Gwon Y, Narayanan MA, Garcia S, Sandoval Y, Brilakis ES, Basir MB, Turagam MK, Khandelwal A, Mena-Hurtado C, Mamas MA, Abbott JD, Bhatt DL, Velagapudi P.
    JACC Cardiovasc Interv; 2020 Jul 13; 13(13):1571-1582. PubMed ID: 32646699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.